According to Rigel Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$8.5 M. In 2023 the company made an earning of -S$23.74 M an increase over its 2022 earnings that were of -S$71.47 M.The earnings displayed on this page is the company's Pretax Income.